# THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure

Study · id `cardio:ct-nct01640639` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01640639](<https://clinicaltrials.gov/study/NCT01640639>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01640639

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT01640639. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT01640639, source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01640639, source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01640639, source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01640639, source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01640639, source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01640639-2013-03-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure
- Acronym: THUNDER
- Condition: Congestive Heart Failure
- Intervention (Drug): Thalidomide
- Intervention (Drug): Placebo
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

## Provenance

Content hash: 6ad76e62b505ff3c7662195cc62d7bcbee673a885b1a9b2907487b38a03de605
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
